Vanderbilt University School of Medicine
Last Modified: August 4, 2006
Conference Dates: October 28-29, 2006
Conference Location: Braselton, GA
Sponsoring Group: Vanderbilt University School of Medicine
Conference Web Page URL: www.thecbce.com
Topics Covered: An increased understanding of the biology and etiology of cancer has resulted in an improved ability to design therapeutic regimens. Rationally designed therapeutics, including targeted agents, modified dosing strategies, and strategic combinations of agents and therapeutic modalities, have led to improved survival without significant increases in treatment-related toxicities. This conference will update attendees on recent advances in the treatment of cancer, including a review of the biology of specific tumor types and currently available data from emerging clinical trials.
Conference Objectives: Please see www.thecbce.com for further details
Who Should Attend: This activity is designed for community oncologists, radiation oncologists, surgical oncologists, oncology nurses, research nurses/coordinators, and other health care professionals interested in the treatment of patients with cancer.
Conference Agenda: Please see www.thecbce.com for further details.
Registration Information: Please see www.thecbce.com for further details.
Conference Fees: Please see www.thecbce.com for further details
Continuing Education: Yes
Jan 20, 2012 - The PAM4-antigen immunoassay detects approximately two-thirds of patients with stage 1 pancreatic ductal adenocarcinoma; and use of spatial-domain low-coherence quantitative phase microscopy accurately distinguishes non-dysplastic intestinal metaplasia from high-grade dysplasia or esophageal adenocarcinoma in patients with Barrett's esophagus, according to two studies presented at the American Society of Clinical Oncology's annual Gastrointestinal Cancers Symposium, held from Jan. 19 to 21 in San Francisco.
Jan 20, 2012
Feb 9, 2011
Apr 16, 2014